sb 216763 has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, SH; Kim, YC; Kwon, HY; Lee, JH; Sohn, EJ; Son, HS; Woo, HJ; Yun, M | 1 |
1 other study(ies) available for sb 216763 and Liver Neoplasms
Article | Year |
---|---|
Activation of AMP-activated protein kinase and phosphorylation of glycogen synthase kinase3 β mediate ursolic acid induced apoptosis in HepG2 liver cancer cells.
Topics: AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Adhesion Molecules; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hep G2 Cells; Humans; Indoles; Leupeptins; Liver Neoplasms; Maleimides; Membrane Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; TOR Serine-Threonine Kinases; Triterpenes; Ubiquitination; Ursolic Acid | 2013 |